
THURSDAY, Nov. 25, 2021 (HealthDay News) – Add an inexpensive gout drug to the growing list of medications touted as potential COVID-19 treatments — only to offer no apparent benefit. The anti-inflammatory drug colchicine doesn’t lessen COVID severity, the risk of death or shorten hospital stays, a new study reports. Nor does it lower the… read on > read on >